colgate close housing development fund corp.

115 west 31st street
new york, new york, 10001

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 09, 2013

NYS DOS ID#
4428029

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2013 - COLGATE CLOSE HOUSING DEVELOPMENT FUND CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Trump Family Wedding Planner to Head New York’s Federal Housing Office
    By YAMICHE ALCINDOR and J. DAVID GOODMAN - Friday Jun 16, 2017

    The appointment of Lynne Patton, who planned Eric Trump’s wedding, to head the Department of Housing and Urban Development’s New York office, is raising eyebrows.

    Source: NYT > Home Page
  • ‘I’d Be Hurt and Upset’: Cities Fear Trump’s Cuts to Urban Programs
    By YAMICHE ALCINDOR - Friday Mar 17, 2017

    President Trump’s proposed cuts to the Department of Housing and Urban Development would eliminate programs cities have used to fund things like Meals on Wheels.

    Source: New York Times
  • Greater Minnesota Housing Fund Launches Impact Investment Fund
    By webmaster@philanthropynewsdigest.org (Matt Sinclair) - Thursday Jun 8, 2017

    A public-private partnership, the new fund will support efforts to acquire and preserve affordable housing in the Twin Cities....

    Source: Philanthropy News Digest (PND)
  • De Blasio’s Plan to Create 100,000 Jobs: Find 40,000, and Keep Eyes Open
    By WILLIAM NEUMAN and J. DAVID GOODMAN - Thursday Jun 15, 2017

    Mayor Bill de Blasio announced initiatives toward his goal of creating 100,000 jobs in New York City, but couldn’t say where 60,000 of those would come from.

    Source: NYT > Home Page
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York
  • Five Sites of New York’s L.G.B.T. History
    Monday Jun 19, 2017

    Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.

    Source: NYT > Home Page
  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
    By Frank Vinluan - Tuesday May 30, 2017

    Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]

    Source: Xconomy New York